Financial Statements — CCII
Balance Sheet
(in millions USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 |
|---|
| Cash & Equivalents | 1.46 | 1.75 | -- |
| Short-term Investments | 259.92 | -- | -- |
| Total Current Assets | 1.67 | 1.91 | 0.02 |
| Total Non-current Assets* | 259.94 | 255.65 | 0.38 |
| Total Assets | 261.61 | 257.56 | 0.39 |
| Total Current Liabilities | 0.15 | 0.08 | 0.42 |
| Total Non-current Liabilities* | 10.78 | 10.78 | 0.00 |
| Total Liabilities* | 10.93 | 10.86 | 0.42 |
| Retained Earnings | (9.24) | (8.89) | (0.06) |
| Total Stockholder Equity | (9.24) | (8.89) | (0.03) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 |
|---|
| Selling, General & Admin | 0.40 | 0.35 | 0.31 | 0.03 |
| Operating Income | (0.40) | (0.35) | (0.31) | (0.03) |
| Net Income | 1.87 | 2.12 | 2.28 | (0.03) |
| Basic EPS | -- | -- | -- | 0.00 |
| Diluted EPS | -- | -- | -- | 0.00 |
Cash Flow Statement
(in millions USD)| Metric | Q1
2026 | Q3
2025 |
|---|
| Operating Cash Flow | (0.40) | (0.52) |
| Investing Cash Flow | -- | (253.00) |
| Financing Cash Flow | -- | 255.27 |
